India’s Wockhardt A Target On Hyperactive Deal Street?
This article was originally published in PharmAsia News
Executive Summary
After the Ranbaxy-Sun deal last month, another Indian drug maker, Wockhardt, is speculated to be discussing a transaction for its India business. Although the company has said it has no information to share at present, the stock market is rife with rumors that a deal may be on the table.